| Financial Year |
March 31 2023 |
| Monetary Funds |
865,085,020.60 |
| Held-for-trading Financial Assets |
30,000,000.00 |
| Notes Receivable |
3,590,314.18 |
| Accounts Receivable |
2,360,698,987.45 |
| Advances to Suppliers |
23,604,149.79 |
| Other Receivables |
303,186,463.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
50,554,708.32 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
99,121,328.36 |
| Other Current Assets |
66,173,971.50 |
| Total Current Assets |
3,879,492,033.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
167,873,813.93 |
| Long-term Equity Investment |
428,840,240.47 |
| Investment Properties |
3,877,700.74 |
| Fixed Assetes |
867,661,489.18 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
242,170,549.48 |
| R&D expenses |
-- |
| Goodwill |
152,247,942.25 |
| Long-Term Deferred and Prepaid Expenses |
25,615,435.13 |
| Deferred Income Tax Assets |
65,035,885.08 |
| Other Non-Current Assets |
121,969,282.48 |
| Sub-Total of Non-Current Assets |
2,216,223,661.12 |
| Total Assets |
6,095,715,694.82 |
| Short-Term Loans |
663,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
530,276,587.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
308,523,320.90 |
| Taxes Payable |
88,959,099.01 |
| Interest Payable |
-- |
| Dividend Payable |
13,549,229.12 |
| Other payables |
45,896,169.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
156,683,143.49 |
| Other Current Liabilities |
56,487,081.88 |
| Sub-Total of Current Liabilities |
1,879,535,299.92 |
| Long-term Loans |
118,500,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
219,324,692.36 |
| Deferred Income Tax Liabilities |
20,326,995.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
416,265,129.09 |
| Total Liabilities |
2,295,800,429.01 |
| Paid-In Capital(Or Share Stock) |
332,160,000.00 |
| Capital Surplus |
773,622,375.30 |
| Surplus Reserve |
75,373,049.22 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,268,066,453.01 |
| Minority Stockholder's Interest |
350,693,388.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,449,221,877.53 |
| Owner's Equity（Stockholder's Equity） |
3,799,915,265.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,095,715,694.82 |
